The 12-Month Cost Comparison
| Option | Monthly | 12-Month Total | Includes |
|---|---|---|---|
| Brand Wegovy (self-pay) | $349 | $4,188 | FDA-approved, pre-filled pen |
| Brand Zepbound (self-pay) | $349–399 | $4,188–4,788 | FDA-approved, dual-agonist |
| Compounded sema (flat-rate) | $149–299 | $1,788–3,588 | 503A compounded, vial + syringes |
| Compounded sema (dose-escalating) | $99–449 | $2,400–4,200 | Price changes at each dose step |
| Medicare Bridge | $50 | $600 | Brand-name only, Part D required |
What Brand Gives You That Compounded Doesn't
- FDA review for safety and efficacy — The finished product has been evaluated
- Pre-filled, pre-dosed pens — No drawing from vials, no dosing math
- Consistent manufacturing standards — Same product every time, from an FDA-inspected facility
- Insurance eligibility — Compounded products are generally not covered by insurance
- Medicare Bridge coverage — $50/month for brand-name only
What Compounded Gives You That Brand Doesn't
- Dramatically lower out-of-pocket cost — 30–70% less than brand self-pay
- Dose flexibility — Custom doses not available in brand-name pre-filled pens
- Format options — Some providers offer sublingual drops, tablets, or troches
- No insurance required — Direct pay, no prior authorization needed
The Safety Data You Should Know
The FDA has received 455+ adverse event reports from compounded semaglutide and 320+ from compounded tirzepatide. Many involved dosing errors from multi-dose vials. This doesn't mean all compounded GLP-1 is dangerous — but quality varies significantly between pharmacies. The source matters.
The "Same Active Ingredient" Claim — With Context
Compounded semaglutide contains the same active pharmaceutical ingredient as Wegovy. But "same active ingredient" doesn't mean "identical product." Differences include: the salt form used, excipients and stabilizers, sterility testing protocols, and concentration accuracy.
Think of it like generic medications — the active ingredient is the same, but the FDA's generic approval process verifies bioequivalence. Compounded products don't go through that verification. For most patients, this distinction is academic. For some, it matters.
Embody
Compounded injectable semaglutide with custom metabolic reports. HSA/FSA accepted. 24/7 clinical support.
Compare Now →Sesame Care
Access FDA-approved Wegovy and Zepbound through licensed providers. Same-day appointments, all 50 states. No compounded medications.
Check Eligibility →Our Recommendation
There is no universally "right" answer. Here's our decision framework:
- Choose brand-name if: you have insurance coverage, you qualify for Medicare Bridge ($50/mo), you want pre-filled convenience, or safety certainty is your priority
- Choose compounded if: cost is the primary barrier to treatment, you don't have insurance coverage, you want dose flexibility, and you've verified your provider uses a licensed 503A pharmacy
The worst option is not starting treatment because you're waiting for the perfect choice. Both pathways produce clinically meaningful weight loss.